Related Experiment Video
Updated: Nov 8, 2025

11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.1K
Critical reagent characterization and re-evaluation to ensure long-term stability: two case studies
Teresa M Caiazzo1, Christopher M Shea1, Alison P Joyce1
1Pfizer Inc., BioMedicine Design, One Burtt Road, Andover, MA 01810, USA.
Bioanalysis
|April 22, 2021
Summary
Optimizing reagent conjugation and purification conditions, particularly pH, significantly reduces aggregate formation in ligand-binding assays. This proactive characterization ensures long-term reagent stability and assay performance.
Area of Science:
- Biopharmaceutical Analysis
- Assay Development and Validation
Background:
- Increasing background signal in ligand-binding assays can compromise data reliability.
- Critical reagent characterization is essential for maintaining assay performance and stability.
Purpose of the Study:
- To investigate conjugation conditions for a bispecific protein using SULFO-TAG NHS-Ester™ ruthenium.
- To resolve issues related to increased ligand-binding assay background signal.
- To identify optimal conditions for reducing aggregate formation in critical reagents.
Main Methods:
- Functional and biophysical characterization of stability samples.
- Investigated low pH (4.0) for conjugation and formulation buffers.
- Employed pH-specific (3.0) purification conditions for reagent antibodies.
Main Results:
- Low pH (4.0) conjugation and formulation buffers effectively decreased aggregate formation.
- pH-specific (3.0) purification reduced aggregate levels in a mouse IgG3 reagent antibody from 37% to <5%.
- Demonstrated the link between specific pH conditions and reduced aggregation.
Conclusions:
- Biophysical and functional characterization of critical reagents is vital for proactive stability management.
- Optimized pH conditions for conjugation, formulation, and purification are key to mitigating assay background.
- Recommends a risk-based approach for establishing reagent re-evaluation intervals.

